Suzuken Co., Ltd.

9987.T
Medical Distribution
2026/09/18 Updated
Market Cap: $2.3B (¥354.9B)
Stock Price: $33.85 (¥5,322)
Exchange Rate: 1 USD = ¥157.23

Notice regarding the resolution on share buyback

Decision to acquire treasury stock. Upper limit of 4,000,000 shares (5.91% of outstanding shares) with a total amount cap of 18 billion yen, and a period from September 1, 2026 to March 19, 2027. Following a stock split, the upper limit is planned to expand to 8,000,000 shares.

Importance:
Page Updated: August 28, 2026
IR Disclosure Date: August 28, 2026

Key Figures

  • Total number of shares that may be acquired: 4,000,000 shares (upper limit)
  • Total amount of acquisition price: 180 hundred million yen (upper limit)
  • Upper limit after stock split: 8,000,000 shares
  • Current treasury stock: 4,492,999 shares

AI要約

Purpose and overview of the share buyback

The company has decided to execute treasury stock acquisition to respond to changes in the management environment, aiming to implement a flexible capital policy. The targets are common stock, with an upper limit of 5.91% of outstanding shares (4,000,000 shares). The total acquisition value is capped at 18 billion yen, and the acquisition period is from September 1, 2026 to March 19, 2027.

Impact of the stock split and future upper limit

A stock split (1 share into 2 shares for ordinary shares) is scheduled to take effect on October 1, 2026. After the stock split, the total number of shares that may be acquired is capped at 8,000,000 shares. The current treasury stock holding stands at 4,492,999 shares.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Suzuken Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →